LivaNova PLC (NASDAQ:LIVN) Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas cut its stake in shares of LivaNova PLC (NASDAQ:LIVN) by 49.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,071 shares of the company’s stock after selling 10,948 shares during the quarter. Teacher Retirement System of Texas’ holdings in LivaNova were worth $435,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. UMB Bank n.a. lifted its stake in LivaNova by 340.5% in the first quarter. UMB Bank n.a. now owns 837 shares of the company’s stock valued at $33,000 after buying an additional 647 shares during the last quarter. Russell Investments Group Ltd. grew its stake in LivaNova by 17.1% during the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company’s stock valued at $70,000 after acquiring an additional 219 shares in the last quarter. Sterling Capital Management LLC grew its stake in shares of LivaNova by 800.6% in the 4th quarter. Sterling Capital Management LLC now owns 1,621 shares of the company’s stock valued at $75,000 after buying an additional 1,441 shares in the last quarter. Central Pacific Bank Trust Division lifted its holdings in LivaNova by 7.0% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,407 shares of the company’s stock worth $173,000 after purchasing an additional 290 shares during the last quarter. Finally, Optimize Financial Inc acquired a new position in shares of LivaNova during the fourth quarter worth approximately $208,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on LIVN. Wall Street Zen cut LivaNova from a “strong-buy” rating to a “buy” rating in a research report on Thursday, May 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $64.00 price target on shares of LivaNova in a research report on Tuesday, May 13th. Robert W. Baird increased their price objective on LivaNova from $55.00 to $61.00 and gave the stock an “outperform” rating in a report on Thursday, May 8th. Wolfe Research upgraded LivaNova from a “peer perform” rating to an “outperform” rating and set a $60.00 price target for the company in a research note on Tuesday, May 20th. Finally, Barclays cut their price objective on LivaNova from $56.00 to $55.00 and set an “equal weight” rating for the company in a research report on Thursday, May 8th. One analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, LivaNova currently has an average rating of “Buy” and an average target price of $59.29.

LivaNova Stock Down 1.0%

Shares of NASDAQ:LIVN opened at $42.54 on Friday. The business’s 50-day moving average is $44.81 and its 200-day moving average is $43.21. LivaNova PLC has a 1 year low of $32.48 and a 1 year high of $57.35. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.58 and a quick ratio of 1.37. The company has a market capitalization of $2.32 billion, a price-to-earnings ratio of -10.40 and a beta of 0.90.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.